This is Y.

Because when COPD symptom relief is consistent,* each day has possibilities1

*For patients with COPD who may benefit from nebulized maintenance therapy, consider YUPELRI—the first and only once-daily nebulized LAMA that improves lung function for a full 24 hours of better breathing.1,2

Why YUPELRI

Not an actual patient.

Not an actual patient.

24-hour efficacy

YUPELRI delivers a full 24 hours of efficacy in a single daily dose.1

Review Efficacy

Review the multiple factors that can play an important role in shaping treatment decisions.

This is Y.

Identifying Appropriate
Patients

See why many of your patients with ongoing symptoms may be candidates for nebulized therapy.

See Patient Types

Convenient Dosing

Once-daily YUPELRI is administered in ~8 minutes using any standard jet nebulizer.1

View Administration

Comprehensive
coverage

Learn about coverage options and The YUPELRI Hub, a dedicated prescription fulfillment service for your patients.

YUPELRI is covered through the Medicare Part B benefit.

Not actual size.

Helpful resources

Explore useful tools designed to help you and your patients throughout the treatment journey.

Find Resources

COPD=chronic obstructive pulmonary disease; GOLD=Global Initiative for Chronic Obstructive Lung Disease; LAMA=long-acting muscarinic antagonist.